Home / News / Deloitte Report Promotes Efficient Cancer Drug Development

Deloitte Report Promotes Efficient Cancer Drug Development

Photo: Zbigniew Nowak

Deloitte has released a report highlighting successful cancer drug development approaches that could help the biotech and healthcare IT world in the future.

The report, titled “Innovative Strategies for Oncology Drug Development,” benchmarks 150 biotech companies and how they leveraged FDA and other regulatory benefits to their advantage.

“Scientific innovation has brought measurable rewards such as reduced development times, higher success rates for cancer drugs, and increased investment and activity across the biopharmaceutical industry,” said Lisa Natanson, senior analyst, Deloitte Recap LLC. “We see clear patterns of successful drug development from this study of a defined set of biotechnology companies that have produced innovative cancer drugs in the last decade.”

Follow me on Facebook

Check Also

Rhys Williams Joins Cubic as VP, Treasurer

Rhys Williams, a financial executive with more than 20 years of experience, has been appointed …

Leave a Reply

Your email address will not be published. Required fields are marked *